http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113209089-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113209089-B |
| titleOfInvention | Application of small molecular compound in preparation of anti-depression drugs |
| abstract | The invention discloses application of a small molecular compound, wherein the small molecular compound is N- (2- (1- (4-chlorphenyl) -5-hydroxy-3-phenyl-1 hydrogen-pyrazol-4-yl) -2-acetyl) -4-methyl-N-propylbenzamide having the chemical formula: the small molecular compound has stronger inhibition effect on MIF, obvious inhibition effect on microglial cell activation and inflammatory factor release, small cytotoxicity and good development prospect, is expected to be developed into a novel MIF inhibitor, a novel anti-central system inflammation drug, and particularly a novel drug for treating depression. |
| priorityDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.